Track the 강스템바이오텍 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 강스템바이오텍 has logged 35 reports. Market capitalisation: €210.7bn. The latest transaction was disclosed on 3 April 2026 (Purchase). Among the most active insiders: 세종. All data is free.
35
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
2 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,559 of 27,969 companies
20.3
score / 100
Value
22
Quality
19
FCF yld-5.9%
Earn yld-5.0%
EV/EBITDA·
ROE-48%
Gross mgn24%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.